These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 19082568)
21. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial. Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265 [TBL] [Abstract][Full Text] [Related]
22. Rocuronium-induced neuromuscular block and sugammadex in pediatric patient with duchenne muscular dystrophy: A case Report. Kim JE; Chun HR Medicine (Baltimore); 2017 Mar; 96(13):e6456. PubMed ID: 28353578 [TBL] [Abstract][Full Text] [Related]
23. Sugammadex: a revolutionary approach to neuromuscular antagonism. Kopman AF Anesthesiology; 2006 Apr; 104(4):631-3. PubMed ID: 16571954 [No Abstract] [Full Text] [Related]
24. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine. Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265 [TBL] [Abstract][Full Text] [Related]
25. Reversal of neuromuscular block with a selective relaxant-binding agent: sugammadex. Ren WH; Jahr JS Am J Ther; 2009; 16(4):295-9. PubMed ID: 19535969 [TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials. Carron M; Zarantonello F; Tellaroli P; Ori C J Clin Anesth; 2016 Dec; 35():1-12. PubMed ID: 27871504 [TBL] [Abstract][Full Text] [Related]
27. [Characteristics and effectiveness of sugammadex]. Otomo S; Sasakawa T; Kunisawa T; Iwasaki H Masui; 2013 Jan; 62(1):27-37. PubMed ID: 23431891 [TBL] [Abstract][Full Text] [Related]
28. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study. Sorgenfrei IF; Norrild K; Larsen PB; Stensballe J; Ostergaard D; Prins ME; Viby-Mogensen J Anesthesiology; 2006 Apr; 104(4):667-74. PubMed ID: 16571960 [TBL] [Abstract][Full Text] [Related]
29. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients. Plaud B; Meretoja O; Hofmockel R; Raft J; Stoddart PA; van Kuijk JH; Hermens Y; Mirakhur RK Anesthesiology; 2009 Feb; 110(2):284-94. PubMed ID: 19194156 [TBL] [Abstract][Full Text] [Related]
30. [Sugammadex, a new drug for reversion of muscle relaxants]. Kvolik S; Ikić V; Jukić M Lijec Vjesn; 2011; 133(3-4):106-10. PubMed ID: 21612107 [TBL] [Abstract][Full Text] [Related]
31. Effects of sugammadex doses up to 32 mg/kg alone or in combination with rocuronium or vecuronium on QTc prolongation: a thorough QTc study. de Kam PJ; van Kuijk J; Prohn M; Thomsen T; Peeters P Clin Drug Investig; 2010; 30(9):599-611. PubMed ID: 20568829 [TBL] [Abstract][Full Text] [Related]
32. [Sugammadex: something new to improve patient safety or simply a gadget?]. Plaud B Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S64-9. PubMed ID: 19887280 [TBL] [Abstract][Full Text] [Related]
33. [Possible clinical potential in reverting muscular block with sugammadex in anaesthesia and surgery]. Øberg E; Claudius C Ugeskr Laeger; 2013 Feb; 175(7):428-32. PubMed ID: 23402253 [TBL] [Abstract][Full Text] [Related]
34. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies. Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619 [TBL] [Abstract][Full Text] [Related]
35. [Sugammadex: a new approach to muscle relaxation and its reversal]. Duvaldestin P Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S39-40. PubMed ID: 19887275 [No Abstract] [Full Text] [Related]